By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher said after the close of the market on Monday that it plans on offering 17.5 million shares of its common stock in a public offering.

Danaher hasn't yet priced its offering, but the firm's shares closed Monday at $51.33 on the New York Stock Exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.